MLTX
Price
$58.65
Change
+$2.90 (+5.20%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
3.54B
77 days until earnings call
RAPP
Price
$16.38
Change
-$1.25 (-7.09%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
643.46M
65 days until earnings call
Interact to see
Advertisement

MLTX vs RAPP

Header iconMLTX vs RAPP Comparison
Open Charts MLTX vs RAPPBanner chart's image
MoonLake Immunotherapeutics
Price$58.65
Change+$2.90 (+5.20%)
Volume$19.31K
Capitalization3.54B
Rapport Therapeutics
Price$16.38
Change-$1.25 (-7.09%)
Volume$6.91K
Capitalization643.46M
MLTX vs RAPP Comparison Chart in %
Loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. RAPP commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a StrongBuy and RAPP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (MLTX: $55.75 vs. RAPP: $17.63)
Brand notoriety: MLTX and RAPP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 139% vs. RAPP: 214%
Market capitalization -- MLTX: $3.72B vs. RAPP: $597.47M
MLTX [@Biotechnology] is valued at $3.72B. RAPP’s [@Biotechnology] market capitalization is $597.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whileRAPP’s FA Score has 1 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • RAPP’s FA Score: 1 green, 4 red.
According to our system of comparison, RAPP is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 3 TA indicator(s) are bullish while RAPP’s TA Score has 4 bullish TA indicator(s).

  • MLTX’s TA Score: 3 bullish, 4 bearish.
  • RAPP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RAPP is a better buy in the short-term than MLTX.

Price Growth

MLTX (@Biotechnology) experienced а -0.25% price change this week, while RAPP (@Biotechnology) price change was +19.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

MLTX is expected to report earnings on Nov 18, 2025.

RAPP is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.54B) has a higher market cap than RAPP($643M). MLTX YTD gains are higher at: 2.955 vs. RAPP (-0.620). RAPP has higher annual earnings (EBITDA): -100.79M vs. MLTX (-196.98M). MLTX has more cash in the bank: 425M vs. RAPP (260M). RAPP has less debt than MLTX: RAPP (11.9M) vs MLTX (75.8M). MLTX (0) and RAPP (0) have equivalent revenues.
MLTXRAPPMLTX / RAPP
Capitalization3.54B643M551%
EBITDA-196.98M-100.79M195%
Gain YTD2.955-0.620-477%
P/E RatioN/A14.69-
Revenue00-
Total Cash425M260M163%
Total Debt75.8M11.9M637%
TECHNICAL ANALYSIS
Technical Analysis
MLTXRAPP
RSI
ODDS (%)
Bearish Trend 7 days ago
76%
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
69%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bullish Trend 5 days ago
67%
Bullish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 6 days ago
67%
Bullish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
58%
Bullish Trend 5 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 5 days ago
90%
Declines
ODDS (%)
Bearish Trend 8 days ago
72%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
33%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEPSX14.140.07
+0.48%
JPMorgan Equity Premium Income R5
SGHIX11.67-0.02
-0.17%
Saturna Global High Income
EZTGX55.42-0.33
-0.59%
Eaton Vance Tx-Mgd Growth 1.2 C
VRSCX23.79-0.24
-1.00%
Voya SmallCap Opportunities Port R6
GLVNX81.81-1.02
-1.23%
Invesco Global Focus R

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XNCR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+1.73%
XNCR - MLTX
47%
Loosely correlated
+0.99%
IDYA - MLTX
46%
Loosely correlated
-1.52%
XENE - MLTX
44%
Loosely correlated
+0.28%
AURA - MLTX
44%
Loosely correlated
-2.64%
NRIX - MLTX
42%
Loosely correlated
-0.74%
More

RAPP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPP has been loosely correlated with OCUL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPP jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPP
1D Price
Change %
RAPP100%
+4.94%
OCUL - RAPP
43%
Loosely correlated
-2.48%
DAWN - RAPP
40%
Loosely correlated
-1.05%
MLTX - RAPP
39%
Loosely correlated
+1.73%
DNLI - RAPP
39%
Loosely correlated
-2.43%
MNMD - RAPP
39%
Loosely correlated
-9.20%
More